Should MARS and Prometheus be used in patients with liver disease? - Wikidata - wikimedia - TriplyDB

Should MARS and Prometheus be used in patients with liver disease?

Should MARS and Prometheus be used in patients with liver disease?

http://www.wikidata.org/entity/Q38193890

about

Should MARS and Prometheus be used in patients with liver disease?

http://www.wikidata.org/entity/Q38193890

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Should MARS and Prometheus be used in patients with liver disease?

@en

type

label

Should MARS and Prometheus be used in patients with liver disease?

@en

prefLabel

Should MARS and Prometheus be used in patients with liver disease?

@en

P1433

Q38193890-8A531CA0-AA8A-488A-849C-C9F3DBF4222E

P1476

Q38193890-3AB00E66-9191-47EB-886C-A475744D2891

P2093

Q38193890-94317FC4-68B9-4835-90B5-BC96053E3AF1

P2860

Q38193890-3C164C99-F7DD-4D08-8B89-79E6497CF990

Q38193890-4BC49F6A-E635-41B6-A55D-435BB547E442

Q38193890-67451B68-2E30-4E7C-BFA2-C39A3DC5889E

Q38193890-852575D5-4EC0-4CC7-BC36-A2A8A86FE92A

Q38193890-8E5D6A8C-51C6-455F-B7F1-6976DC3CFDC5

Q38193890-A98E067D-F330-4EA1-A7C9-12DC7FCA18FE

Q38193890-AD8F1E75-75CA-4A0A-BF99-A0CEA8EF765E

Q38193890-BEABB7AA-08D8-4D55-A834-393B76A78B44

Q38193890-E3943845-58D6-4B3F-AA2C-0BFD948F9DCB

Q38193890-E70C08A0-F1F7-4F94-86AD-64BA2BAC966B

P304

Q38193890-BF36991D-76DA-4F02-A0CE-22B2A28C4394

P31

Q38193890-E1D8AF40-A39C-459E-B3DD-177802A88131

P356

Q38193890-704AB459-EFE0-4221-8627-7B1A5C35F45E

P433

Q38193890-EAE5B61D-C473-411A-BB87-833BE0AAD756

P478

Q38193890-161CC12A-FF00-4C87-A810-F63D6D10E0AF

P577

Q38193890-C9733F16-F4C2-48C0-8E12-AD0088B521DC

P5875

Q38193890-741884C9-D8A1-4865-85F8-14324CC82A9A

P698

Q38193890-D241F3CD-60E0-4FC2-B033-4DD393208C5D

P356

P1433

Seminars in Dialysis

P1476

Should MARS and Prometheus be used in patients with liver disease?

@en

P2093

Thomas A Gonwa

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

Systematic review and meta-analysis of survival following extracorporeal liver support.

Prometheus--a new extracorporeal system for the treatment of liver failure.

Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.

Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation.

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.

Renal replacement therapy in special settings: extracorporeal support devices in liver failure.

Artificial liver support devices as treatment option for liver failure.

Extracorporeal liver support.

P304

228-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/SDI.12213

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260606479

http://www.w3.org/2001/XMLSchema#string

P698

24601988

http://www.w3.org/2001/XMLSchema#string